Tanya Parish

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 39

Top Venues

PloS one

Microbiology spectrum

Antimicrobial agents and chemotherapy

ACS infectious diseases

Seattle Children’s Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Seattle Children’s Hospital Dec 30 2019

United States

Senior Investigator :: Center for Global Infectious Disease Research

Infectious Disease Research Institute Nov 01 2007 - Dec 24 2019

United States

Senior Vice President, Drug Discovery :: TB Discovery Research

Publications

Shilah Bonnett, Jo-Ann Jee, Somsundaram Chettiar, Yulia Ovechkina, Aaron Korkegian, Eric Greve, Joshua Odingo, Tanya Parish
Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis. Microbiology spectrum (2023)
Shilah Bonnett, Jo-Ann Jee, Somsundaram Chettiar, Yulia Ovechkina, Aaron Korkegian, Eric Greve, Joshua Odingo, Tanya Parish
Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis. Microbiology spectrum 11 (1) (2023)
Shilah Bonnett, Jo-Ann Jee, Somsundaram Chettiar, Yulia Ovechkina, Aaron Korkegian, Eric Greve, Joshua Odingo, Tanya Parish
Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis. Microbiology spectrum 11 (1) (2023)
Shilah Bonnett, Jo-Ann Jee, Somsundaram Chettiar, Yulia Ovechkina, Aaron Korkegian, Eric Greve, Joshua Odingo, Tanya Parish
Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis. Microbiology spectrum 11 (1) (2023)
Sara Ahmed, Sultan Chowdhury, James Gomez, Deborah T Hung, Tanya Parish
Benzene Amide Ether Scaffold is Active against Non-replicating and Intracellular Mycobacterium tuberculosis . ACS infectious diseases (2023)
Bryan Berube, Aditi Deshpande, Amala Bhagwat, Tanya Parish
Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor. bioRxiv : the preprint server for biology (2023)
Bryan Berube, Aditi Deshpande, Amala Bhagwat, Tanya Parish
Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor. bioRxiv : the preprint server for biology (2023)
Tanya Parish
The driving force for mycolic acid export by mycobacterial MmpL3 is proton translocation. Proceedings of the National Academy of Sciences of the United States of America 119 (33) (2022)
Catherine Shelton, Matthew McNeil, Renee Allen, Lindsay Flint, Dara Russell, Bryan Berube, Aaron Korkegian, Yulia Ovechkina, Tanya Parish
Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 66 (4) (2022)
Ben S Gold, Jun Zhang, Landys Lopez Quezada, Julia Roberts, Yan Ling, Madeleine Wood, Wasima Shinwari, Laurent Goullieux, Christine Roubert, Laurent Fraisse, Eric Bacqué, Sophie Lagrange, Bruno Filoche-Rommé, Michal Vieth, Philip A Hipskind, Louis N Jungheim, Jeffrey Aubé, Sarah M Scarry, Stacey L McDonald, Kelin Li, Andrew Perkowski, Quyen Nguyen, Veronique Anne Dartois, Matthew Zimmerman, David B Olsen, Katherine Young, Shilah Bonnett, Douglas Joerss, Tanya Parish, Helena I M Boshoff, Kriti Arora, Clifton E Barry, Laura Guijarro, Sara Anca, Joaquín Rullas, Beatriz Rodríguez-Salguero, Maria S Martínez-Martínez, Esther Porras-De Francisco, Mónica Cacho, David Barros Aguirre, Paul W Smith, Steven J Berthel, Carl Nathan, Robert H Bates
Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions. ACS infectious diseases 8 (3) (2022)
Samuel Njikan, Sara Ahmed, Alyssa Manning, Divya Awasthi, Yulia Ovechkina, Sultan Chowdhury, Arielle Butts, Tanya Parish
Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular Mycobacterium tuberculosis . Microbiology spectrum 10 (3) (2022)
Kritee Mehdiratta, Shubham Singh, Sachin Sharma, Rashmi S Bhosale, Rahul Choudhury, Dattatraya P Masal, Alzu Manocha, Bhushan Dilip Dhamale, Naseem Khan, Vivekanand Asokachandran, Pooja Sharma, Melanie Ikeh, Amanda C Brown, Tanya Parish, Anil K Ojha, Joy Sarojini Michael, Mohammed Faruq, Guruprasad R Medigeshi, Debasisa Mohanty, Dumbala Srinivasa Reddy, Vivek T Natarajan, Siddhesh S Kamat, Rajesh S Gokhale
Kupyaphores are zinc homeostatic metallophores required for colonization of Mycobacterium tuberculosis . Proceedings of the National Academy of Sciences of the United States of America 119 (8) (2022)
Luiza Galina, Fernanda S M Hopf, Bruno Lopes Abbadi, Nathalia D de Moura Sperotto, Alexia M Czeczot, Mario Alejandro Duque-Villegas, Marcia Alberton Perello, Letícia Beatriz Matter, Eduardo Vieira de Souza, Tanya Parish, Pablo Machado, Luiz A Basso, Cristiano Valim Bizarro
Evaluation of 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase (DAHPS) as a Vulnerable Target in Mycobacterium tuberculosis. Microbiology spectrum 10 (4) (2022)
Gregory S Basarab, Sandeep Ghorpade, Liezl Gibhard, Rudolf Mueller, Mathew Njoroge, Nashied Peton, Preshendren Govender, Lisa M Massoudi, Gregory Thomas Robertson, Anne J Lenaerts, Helena Ingrid Boshoff, Douglas Joerss, Tanya Parish, Thomas F Durand-Reville, Manos Perros, Vinayak Singh, Kelly Chibale
Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones. Antimicrobial agents and chemotherapy 66 (4) (2022)
Catherine D Shelton, Matthew B McNeil, Julie V Early, Thomas R Ioerger, Tanya Parish
Correction for Shelton et al., "Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis". Antimicrobial agents and chemotherapy 66 (8) (2022)
Mai B Thayer, Tanya Parish
Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis. PloS one 16 (1) (2021)
Candice Soares de Melo, Vinayak Singh, Alissa Myrick, Sandile B Simelane, Dale Taylor, Christel Brunschwig, Nina Lawrence, Dirk Schnappinger, Curtis A Engelhart, Anuradha Kumar, Tanya Parish, Qin Su, Timothy G Myers, Helena I M Boshoff, Clifton E Barry, Frederick A Sirgel, Paul D van Helden, Kirsteen I Buchanan, Tracy Bayliss, Simon R Green, Peter C Ray, Paul G Wyatt, Gregory S Basarab, Charles J Eyermann, Kelly Chibale, Sandeep R Ghorpade
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action Studies. Journal of medicinal chemistry 64 (1) (2021)
Catherine D Shelton, Matthew B McNeil, Julie V Early, Thomas R Ioerger, Tanya Parish
Deletion of Rv2571c confers resistance to arylamide compounds in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy (2021)
Ankita Punetha, Keith D Green, Atefeh Garzan, Nishad Thamban Chandrika, Melisa J Willby, Allan H Pang, Caixia Hou, Selina Y L Holbrook, Kyle Krieger, James E Posey, Tanya Parish, Oleg V Tsodikov, Sylvie Garneau-Tsodikova
Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance. RSC medicinal chemistry 12 (11) (2021)
Lindsay Flint, Aaron Korkegian, Tanya Parish
InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis. PloS one 15 (11) (2020)
Tanya Parish
In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection. Expert opinion on drug discovery 15 (3) (2020)
Matthew B McNeil, Theresa O'Malley, Devon Dennison, Catherine D Shelton, Bjorn Sunde, Tanya Parish
Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors. mSphere 5 (5) (2020)
Matthew B McNeil, Somsundaram Chettiar, Divya Awasthi, Tanya Parish
Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis. Access microbiology 1 (1) (2019)
Julie V Early, Steven Mullen, Tanya Parish
A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis. PloS one 14 (10) (2019)
Joshua O Odingo, Julie V Early, Jake Smith, James Johnson, Mai A Bailey, Megan Files, Junitta Guzman, Juliane Ollinger, Aaron Korkegian, Anuradha Kumar, Yulia Ovechkina, Tanya Parish
8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis. Drug development research 80 (5) (2019)
Roberto A Crespo, Qun Dang, Nian E Zhou, Liam M Guthrie, Thomas C Snavely, Wen Dong, Kimberly A Loesch, Takao Suzuki, Lanying You, Wei Wang, Theresa O'Malley, Tanya Parish, David B Olsen, James C Sacchettini
Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase. Journal of medicinal chemistry 62 (9) (2019)
Héctor Ricardo Morbidoni, Agustina I de la Iglesia, Virginia Figueroa, Cecilia Beatriz Di Capua, Thomas R Ioerger, Tanya Parish
Mutations in the anti-sigma H factor RshA confer resistance to econazole and clotrimazole in Mycobacterium smegmatis. Access microbiology 1 (10) (2019)
Juliane Ollinger, Anuradha Kumar, David M Roberts, Mai A Bailey, Allen Casey, Tanya Parish
A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis. PloS one 14 (1) (2019)
Jake Smith, Heather Wescott, Julie Early, Steven Mullen, Junitta Guzman, Joshua Odingo, Jason Lamar, Tanya Parish
Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosis membrane potential. MedChemComm 10 (6) (2019)
Laura A T Cleghorn, Peter C Ray, Joshua Odingo, Anuradha Kumar, Heather Wescott, Aaron Korkegian, Thierry Masquelin, Abraham Lopez Moure, Caroline Wilson, Susan Davis, Margaret Huggett, Penelope Turner, Alasdair Smith, Ola Epemolu, Fabio Zuccotto, Jennifer Riley, Paul Scullion, Yoko Shishikura, Liam Ferguson, Joaquin Rullas, Laura Guijarro, Kevin D Read, Simon R Green, Phil Hipskind, Tanya Parish, Paul G Wyatt
Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB. Journal of medicinal chemistry 61 (15) (2018)
Eduard Melief, Rachel Kokoczka, Megan Files, Mai Ann Bailey, Torey Alling, Hongye Li, James Ahn, Ayesha Misquith, Aaron Korkegian, David Roberts, James Sacchettini, Tanya Parish
Construction of an overexpression library for Mycobacterium tuberculosis. Biology methods & protocols 3 (1) (2018)
Yi Xia, Yasheen Zhou, David S Carter, Matthew B McNeil, Wai Choi, Jason Halladay, Pamela W Berry, Weimin Mao, Vincent Hernandez, Theresa O'Malley, Aaron Korkegian, Bjorn Sunde, Lindsay Flint, Lisa K Woolhiser, Michael S Scherman, Veronica Gruppo, Courtney Hastings, Gregory T Robertson, Thomas R Ioerger, Jim Sacchettini, Peter J Tonge, Anne J Lenaerts, Tanya Parish, Mrk Alley
Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA. Life science alliance 1 (3) (2018)
Samuel Njikan, Alyssa J Manning, Yulia Ovechkina, Divya Awasthi, Tanya Parish
High content, high-throughput screening for small molecule inducers of NF-κB translocation. PloS one 13 (6) (2018)
Shilah A Bonnett, Devon Dennison, Megan Files, Anumita Bajpai, Tanya Parish
A class of hydrazones are active against non-replicating Mycobacterium tuberculosis. PloS one 13 (10) (2018)
Julie Early, Juliane Ollinger, Crystal Darby, Torey Alling, Steven Mullen, Allen Casey, Ben S Gold, Jason Ochoada, Todd Wiernicki, Thierry Masquelin, Carl Nathan, Philip A Hipskind, Tanya Parish
Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis. ACS infectious diseases 5 (2) (2018)
Paul Carroll, Julian Muwanguzi-Karugaba, Tanya Parish
Codon-optimized DsRed fluorescent protein for use in Mycobacterium tuberculosis. BMC research notes 11 (1) (2018)
Sheo B Singh, Joshua Odingo, Mai A Bailey, Bjorn Sunde, Aaron Korkegian, Theresa O'Malley, Yulia Ovechkina, Thomas R Ioerger, James C Sacchettini, Katherine Young, David B Olsen, Tanya Parish
Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis. BMC research notes 11 (1) (2018)
Mai Ann Bailey, Hana Na, Malcolm S Duthie, Thomas P Gillis, Ramanuj Lahiri, Tanya Parish
Nitazoxanide is active against Mycobacterium leprae. PloS one 12 (8) (2017)
N Susantha Chandrasekera, Bryan J Berube, Gauri Shetye, Somsundaram Chettiar, Theresa O'Malley, Alyssa Manning, Lindsay Flint, Divya Awasthi, Thomas R Ioerger, James Sacchettini, Thierry Masquelin, Philip A Hipskind, Joshua Odingo, Tanya Parish
Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB. ACS infectious diseases 3 (12) (2017)

Tanya Parish.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tanya Parish